Search Results
177Lu-DOTATATE in patients with well-differentiated, high-grade NETs
Dr. Chauhan on the Role of 177Lu-Dotatate in NETs
Final OS from NETTER-1: lutetium-177-DOTATATE in patients with midgut NETs
NETTER-1 update: 177Lu-DOTATATE in patients with midgut neuroendocrine tumors
New Treatment for Neuroendocrine Tumors
Dr. Strosberg on Future of 177Lu-Dotatate Therapy in Neuroendocrine Tumors
Dr. Jonathan R. Strosberg on 177-Lu-Dotatate in Patients With Neuroendocrine Tumors
NETTER-2, Lutetium Lu 177 for well-differentiated NET
Radioisotopic Targeting of NETs: Lutetium-177 Dotatate and What Does the Future Hold? by Dr.Bushnell
NETTER 1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu Dotatate Efficac
Current treatment options for patients with NETs
Lu177 PRRT For Neuroendocrine Tumors Nets
